Dr. Nader Sanai, MD
Claim this profileSt. Joseph's Hospital and Medical Center
Studies Brain Tumor
Studies Glioblastoma
14 reported clinical trials
18 drugs studied
Area of expertise
1Brain Tumor
RB
archival
p16
2Glioblastoma
RB
p16
CDKN2B
Affiliated Hospitals
Clinical Trials Nader Sanai, MD is currently running
Niraparib + Radiation
for Brain Tumor
This is an open-label, multi-center Phase 0 study with an expansion phase that will enroll up to 24 participants with newly-diagnosed glioblastoma and up to 18 recurrent glioma participants with IDH mutation and ATRX loss. The trial will be composed of a Phase 0 component (subdivided into Arm A and B) and a therapeutic expansion phase. Patients with tumors demonstrating a positive PK Response (in Arm A) or a positive PD Response (in Arm B) of the Phase 0 component of the study will graduate to a therapeutic expansion phase that combines therapeutic dosing of niraparib plus standard-of-care fractionated radiotherapy (in Arm A) or niraparib monotherapy (in Arm B) until progression of disease.
Recruiting1 award Phase < 1
BDTX-1535
for Brain Tumor
This study will administer the investigational drug, BDTX-1535 to eligible patients with recurrent high-grade glioma. BDTX-1535 was designed to block a growth signal important to some cancers. BDTX-1535 is being tested in this study to see if it can be given safely to people who have tumors that can be dependent on that growth signal because of changes in a protein called EGFR. These gene changes are called amplifications, mutations, fusions or alterations and are found only in the tumors.
Recruiting1 award Phase < 16 criteria
More about Nader Sanai, MD
Clinical Trial Related2 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Nader Sanai, MD has experience with
- Abemaciclib
- Radiation Therapy
- Ribociclib
- SONALA-001 And Exablate 4000 Type 2
- LY3214996
- Infigratinib
Breakdown of trials Nader Sanai, MD has run
Brain Tumor
Glioblastoma
Malignant Glioma
Diffuse Intrinsic Pontine Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nader Sanai, MD specialize in?
Nader Sanai, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved RB patients, or patients who are archival.
Is Nader Sanai, MD currently recruiting for clinical trials?
Yes, Nader Sanai, MD is currently recruiting for 7 clinical trials in Phoenix Arizona. If you're interested in participating, you should apply.
Are there any treatments that Nader Sanai, MD has studied deeply?
Yes, Nader Sanai, MD has studied treatments such as Abemaciclib, Radiation therapy, Ribociclib.
What is the best way to schedule an appointment with Nader Sanai, MD?
Apply for one of the trials that Nader Sanai, MD is conducting.
What is the office address of Nader Sanai, MD?
The office of Nader Sanai, MD is located at: St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013 United States. This is the address for their practice at the St. Joseph's Hospital and Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.